Ilyang Pharm Net Asset Quality Index
Ilyang Pharm net asset quality index. Ilyang Pharm (007570) has a Net Asset Quality Index of 53.8% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩444.81 Billion minus total liabilities of ₩205.41 Billion yields net assets of ₩239.41 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check cash flow quality index of Ilyang Pharm to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Ilyang Pharm (2002–2024)
Net asset quality index of Ilyang Pharm from 2002 to 2024. This chart shows how Ilyang Pharm's Net Asset Quality Index has evolved across 16 annual periods from 2002 to 2024. As of June 2025, the index stands at 53.8%, representing net assets of ₩239.41 Billion against total assets of ₩444.81 Billion KRW. See 007570 net asset value for net asset value and shareholders' equity analysis.
Ilyang Pharm Net Asset Quality Index by Year (2002–2024)
Ilyang Pharm net asset quality index by year from 2002 to 2024. The table below presents the year-by-year Net Asset Quality Index for Ilyang Pharm from 2002 to 2024, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Ilyang Pharm (007570) total market value.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 56.0% | ₩241.58 Billion | ₩431.21 Billion | ₩189.63 Billion | ▲ +1.0 pp |
| 2023 | 55.1% | ₩196.41 Billion | ₩356.66 Billion | ₩160.25 Billion | ▼ -3.5 pp |
| 2022 | 58.6% | ₩291.85 Billion | ₩498.19 Billion | ₩206.33 Billion | ▲ +3.6 pp |
| 2021 | 55.0% | ₩271.76 Billion | ₩494.27 Billion | ₩222.51 Billion | ▼ -0.8 pp |
| 2020 | 55.8% | ₩244.92 Billion | ₩439.12 Billion | ₩194.19 Billion | ▲ +4.9 pp |
| 2019 | 50.9% | ₩222.74 Billion | ₩437.46 Billion | ₩214.72 Billion | ▲ +2.4 pp |
| 2018 | 48.6% | ₩209.88 Billion | ₩432.25 Billion | ₩222.37 Billion | ▲ +0.2 pp |
| 2017 | 48.3% | ₩210.98 Billion | ₩436.37 Billion | ₩225.39 Billion | ▼ -2.1 pp |
| 2016 | 50.4% | ₩217.35 Billion | ₩431.26 Billion | ₩213.91 Billion | ▲ +1.5 pp |
| 2015 | 48.9% | ₩211.00 Billion | ₩431.63 Billion | ₩220.62 Billion | ▲ +6.3 pp |
| 2014 | 42.6% | ₩183.46 Billion | ₩430.83 Billion | ₩247.37 Billion | ▼ -3.6 pp |
| 2013 | 46.2% | ₩183.88 Billion | ₩398.38 Billion | ₩214.50 Billion | ▲ +1.6 pp |
| 2009 | 44.6% | ₩129.19 Billion | ₩289.86 Billion | ₩160.67 Billion | ▲ +5.1 pp |
| 2004 | 39.5% | ₩75.20 Billion | ₩190.53 Billion | ₩115.33 Billion | ▼ -6.4 pp |
| 2003 | 45.8% | ₩77.13 Billion | ₩168.29 Billion | ₩91.16 Billion | ▲ +2.4 pp |
| 2002 | 43.4% | ₩75.67 Billion | ₩174.24 Billion | ₩98.56 Billion | — |